Search Results - "Pla, María Jesús"

Digital quantification of KI-67 in breast cancer by del Rosario Taco Sanchez, María, Soler-Monsó, Teresa, Petit, Anna, Azcarate, Juan, Lasheras, Alba, Artal, Carmen, Gil, Miguel, Falo, Catalina, Pla, María Jesús, Matias-Guiu, Xavier

“…Ki-67 proliferative index (Ki-67) is a predictive and prognostic factor in breast cancer (BC). However, some international committees do not recommend its use…”
Get full text

Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence by Pernas, Sonia, Gil, Marta, Benítez, Ana, Bajen, Maria Teresa, Climent, Fina, Pla, Maria Jesús, Benito, Enrique, Gumà, Anna, Gutierrez, Cristina, Pisa, Aleydis, Urruticoechea, Ander, Pérez, Javier, Gil Gil, Miguel

“…Background The need for axillary lymph node dissection (ALND) in breast cancer patients with sentinel lymph node (SLN) micrometastases remains controversial…”
Get full text

Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study by Colomé-Ceballos, Lara, Clua-Espuny, Josep Lluís, Ceballos-García, Concepción, Clua-Queralt, Josep, Pla-Farnós, Maria Jesús, Fernández-Sáez, José

“…HPV vaccination coverage rates can vary depending on several factors. The main objective of this study is to identify possible independent prognostic factors…”
Get full text

HPV Vaccination Coverage Rate in a Rural Area: An Observational, Retrospective, and Cohort Study by Colomé-Ceballos, Lara, Clua-Espuny, Josep Lluís, Fernández-Sáez, José, Ceballos-García, Concepción, Andrés-Cubells, Natàlia, Pla-Farnós, Maria Jesús

“…In order to reduce the incidence and mortality rate of cervical cancer, the World Health Organization (WHO) declared the Global Strategy Goal for 2030,…”
Get full text

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group by Mendoza, Nicolás, Ramírez, Isabel, de la Viuda, Esther, Coronado, Pluvio, Baquedano, Laura, Llaneza, Plácido, Nieto, Verónica, Otero, Borja, Sánchez-Méndez, Sonia, de Frutos, Visitación Álvarez, Andraca, Leire, Barriga, Patricio, Benítez, Zully, Bombas, Teresa, Cancelo, Mª. Jesús, Cano, Antonio, Branco, Camil Castelo, Correa, Marta, Doval, José Luis, Fasero, María, Fiol, Gabriel, Garello, Nestor C., Genazzani, Andrea R., Gómez, Ana Isabel, Gómez, Mª. Ángeles, González, Silvia, Goulis, Dimitrios G., Guinot, Misericordia, Hernández, Luis Rolando, Herrero, Sonia, Iglesias, Eva, Jurado, Ana Rosa, Lete, Iñaki, Lubián, Daniel, Martínez, Milagros, Nieto, Aníbal, Nieto, Laura, Palacios, Santiago, Pedreira, Milagros, Pérez-Campos, Ezequiel, Plá, María Jesús, Presa, Jesús, Quereda, Francisco, Ribes, Miriam, Romero, Pablo, Roca, Beatriz, Sánchez-Capilla, Antonio, Sánchez-Borrego, Rafael, Santaballa, Ana, Santamaría, Amparo, Simoncini, Tommaso, Tinahones, Francisco, Calaf, Joaquín

“…•The objective of this project is to create eligibility criteria for the use of menopausal hormone therapy.•This will provide a powerful decision-making tool…”
Get full text

Self‐assessment of a breast care nursing model within a Breast Unit: learning process and keys to improving breast care by Rodriguez‐Ortega, Ana, Ferro, Tàrsila, Pérez, Xavier, Pla Farnós, Maria Jesus, Gil‐Gil, Miguel, López Ojeda, Anna, Borrás, Josep María

“…Aim and objectives To assess the adherence of a nursing care model in a multidisciplinary breast cancer unit in a tertiary hospital to the recommended…”
Get full text

Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review by Fiol, Gabriel, Lete, Iñaki, Nieto, Laura, Santaballa, Ana, Pla, María Jesús, Baquedano, Laura, Calaf, Joaquín, Coronado, Pluvio, de la Viuda, Esther, Llaneza, Plácido, Otero, Borja, Sánchez-Méndez, Sonia, Ramírez, Isabel, Mendoza, Nicolas

“…to develop eligibility criteria for use in non-gynecological cancer patients. We searched all the articles published in peer-reviewed journals up to March…”
Get full text

Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness by Ruiz de Garibay, Gorka, Herranz, Carmen, Llorente, Alicia, Boni, Jacopo, Serra-Musach, Jordi, Mateo, Francesca, Aguilar, Helena, Gómez-Baldó, Laia, Petit, Anna, Vidal, August, Climent, Fina, Hernández-Losa, Javier, Cordero, Álex, González-Suárez, Eva, Sánchez-Mut, José Vicente, Esteller, Manel, Llatjós, Roger, Varela, Mar, López, José Ignacio, García, Nadia, Extremera, Ana I, Gumà, Anna, Ortega, Raúl, Plà, María Jesús, Fernández, Adela, Pernas, Sònia, Falo, Catalina, Morilla, Idoia, Campos, Miriam, Gil, Miguel, Román, Antonio, Molina-Molina, María, Ussetti, Piedad, Laporta, Rosalía, Valenzuela, Claudia, Ancochea, Julio, Xaubet, Antoni, Casanova, Álvaro, Pujana, Miguel Angel

“…[This corrects the article DOI: 10.1371/journal.pone.0132546.]…”
Get full text

Study of breast cancer incidence in patients of lymphangioleiomyomatosis by Nuñez, Olivier, Román, Antonio, Johnson, Simon R., Inoue, Yoshikazu, Hirose, Masaki, Casanova, Álvaro, de Garibay, Gorka Ruiz, Herranz, Carmen, Bueno-Moreno, Gema, Boni, Jacopo, Mateo, Francesca, Petit, Anna, Climent, Fina, Soler, Teresa, Vidal, August, Sánchez-Mut, José Vicente, Esteller, Manel, López, José Ignacio, García, Nadia, Gumà, Anna, Ortega, Raúl, Plà, María Jesús, Campos, Miriam, Ansótegui, Emilio, Molina-Molina, María, Valenzuela, Claudia, Ussetti, Piedad, Laporta, Rosalía, Ancochea, Julio, Xaubet, Antoni, Pollán, Marina, Pujana, Miguel Angel

“…Molecular evidence has linked the pathophysiology of lymphangioleiomyomatosis (LAM) to that of metastatic breast cancer. Following on this observation, we…”
Get full text

Granulomatous mastitis associated with erythema nodosum: A case series of 42 patients by Moreno-Vílchez, Carlos, Llobera-Ris, Clàudia, Penin, Rosa María, Pla, María Jesús, Mitjavila, Francesca, Marcoval, Joaquim

“…Granulomatous mastitis (GM) is defined by the formation of granulomatous inflammation in breast tissue. Erythema nodosum (EN) is a reactive inflammatory…”
Get full text

Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice by Pernas, Sonia, Gil-Gil, Miguel, de Olza, María Ochoa, Gumà, Anna, Climent, Fina, Petit, Anna, Pla, María Jesús, García-Tejedor, Amparo, López-Ojeda, Ana, Falo, Cati, Fernandez-Otega, Adela, Mesia, Carlos, Pérez-Martin, Francisco Javier, Urruticoechea, Ander, Germà, Josep Ramon

“…One of the most efficacious primary therapies in HER2-positive breast cancer was published by the M.D. Anderson group in 2005. This randomized trial evaluated…”
Get full text

Prognostic value of PAM50 in residual breast cancer following neoadjuvant endocrine therapy (NET): A retrospective analysis with long follow-up by Gil Gil, Miguel J., Perez, Francisco Javier, Soler Monso, Teresa, Pascual, Tomas, Galván, Patricia, Pare, Laia, Petit, Anna, Falo, Catalina, Stradella, Agostina, Pla, María Jesús, Salazar, Ramon, Prat, Aleix

“…Abstract only 575 Background: NET is gaining more acceptances for the management of hormonal receptors (HR)-positive breast cancer (BC). To date, the decrease…”
Get full text

Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer by Linares-Galiana, Isabel, Berenguer-Frances, Miguel Angel, Cañas-Cortés, Rut, Pujol-Canadell, Monica, Comas-Antón, Silvia, Martínez, Evelyn, Laplana, Maria, Pérez-Montero, Héctor, Pla-Farnós, María Jesús, Navarro-Martin, Arturo, Nuñez, Miriam, Both, Brigitte, Guedea, Ferran

“…Abstract A detailed understanding of the interactions and the best dose-fractionation scheme of radiation to maximize antitumor immunity have not been fully…”
Get full text

Prophylactic incisional negative pressure wound therapy for gynaecologic malignancies by Martí, Maria Teresa Climent, Fernandez‐Gonzalez, Sergi, Martí, Maria Dolores, Pla, Maria Jesus, Barahona, Marc, Ponce, Jordi

“…Wound complications are an important cause of postoperative morbidity among patients with gynaecologic malignancies. We evaluated whether the placement of…”
Get full text

Five-year results of accelerated partial breast irradiation: A single-institution retrospective review of 289 cases by Laplana, Maria, Cozzi, Salvatore, Najjari, Dina, Martín, Marta Irene, Rodríguez, Gerard, Slocker, Andrea, Sancho, Ismael, Pla, Maria Jesús, García, Marc, Gracia, Ruth, Pera, Joan, Guedea, Ferran, Gutiérrez, Cristina

“…The purpose of the study was to describe our institutional experience with accelerated partial breast irradiation (APBI) using multicatheter brachytherapy with…”
Get full text

Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM®) for accelerated partial breast irradiation (APBI) by Laplana, Maria, García-Marqueta, Marta, Sánchez-Fernández, Juan José, Martínez-Pérez, Evelyn, Pérez-Montero, Héctor, Martínez-Montesinos, Irene, Eraso, Arantxa, Saldaña, Pablo, Martín, Roberto, Martín, Marta Irene, Pla, Maria Jesús, García-Tejedor, Amparo, Guedea, Ferran

“…Purpose To evaluate treatment outcomes in patients with early-stage breast cancer (ESBC) treated with targeted intraoperative radiation therapy (IORT)…”
Get full text

The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures by Fernandez-Gonzalez, Sergi, Falo, Catalina, Pla, Maria Jesus, Pernas, Sonia, Bajen, Maite, Soler, Teresa, Ortega, Raul, Quetglas, Cecilia, Perez-Martin, Xavier, Fernandez Montoli, Maria Eulalia, Campos, Miriam, Varela-Rodriguez, Mar, Ponce, Jordi, Garcia-Tejedor, Amparo

“…The clinical consequence of performing sentinel lymph node biopsy (SLNB) before or after neoadjuvant therapy (NAT) in breast cancer patients remains under…”
Get full text

Robotic transperitoneal infrarenal para-aortic lymphadenectomy with double docking: technique, learning curve and perioperative outcomes by Ponce, Jordi, MDPhD, Barahona, Marc, MD, Pla, Maria Jesus, MD, Rovira, Jordi, MD, García-Tejedor, Amparo, MDPhD, Gil-Ibañez, Blanca, MD, Gaspar, Hugo Manuel, MD, Sabriá, Enric, MD, Bartolomé, Carlos, MD, Martí, Lola, MD

“…Abstract Para-aortic lymphadenectomy (PAL) is a challenging procedure, performed by minimally invasive surgery in very few centers due to its intrinsic…”
Get full text

Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis by Coronado, Pluvio J, Gómez, Ana, Iglesias, Eva, Fasero, María, Baquedano, Laura, Sánchez, Sonia, Ramírez-Polo, Isabel, de la Viuda, Esther, Otero, Borja, Llaneza, Plácido, Mendoza, Nicolás, Lubián, Daniel M

“…Menopause hormone therapy (MHT) effectively alleviates menopausal symptoms. However, it is generally not recommended for breast cancer survivors, although the…”
Get full text

Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years by Domènech, Anna, Benitez, Ana, Bajén, María Teresa, Pla, María Jesús, Gil, Miguel, Martín-Comín, Josep

“…To analyze the rate of axillary recurrences and survival in patients operated on for breast cancer who had not undergone an axillary lymph node dissection…”
Get more information